Botulinum toxin type A vs type B for axillary hyperhidrosis in a case series of patients observed for 6 months.
Department of Neurology, Cittadella Hospital, Padua, Italy. efrasson@ulss15.pd.it
Emma
E
Frasson
Francesco
F
Brigo
Michele
M
Acler
Giuseppe
G
Didonè
Silvana
S
Vicentini
Laura
L
Bertolasi
D000328:Adult; D001365:Axilla; D001905:Botulinum Toxins / Q000009:adverse effects / Q000627:therapeutic use*; D019274:Botulinum Toxins, Type A / Q000009:adverse effects / Q000627:therapeutic use*; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D006945:Hyperhidrosis / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D009465:Neuromuscular Agents / Q000009:adverse effects / Q000627:therapeutic use*; D017060:Patient Satisfaction; D016037:Single-Blind Method; D016896:Treatment Outcome; D055815:Young Adult
D009465:Neuromuscular Agents; C096323:rimabotulinumtoxinB; D001905:Botulinum Toxins; D019274:Botulinum Toxins, Type A